Company registration number 07584643 (England and Wales)
ALTERA HEALTHCARE (IT) UK LTD
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
ALTERA HEALTHCARE (IT) UK LTD
COMPANY INFORMATION
Directors
J Bender
T Richardson
Company number
07584643
Registered office
31 Temple Street
Birmingham
B2 5DB
Auditor
Cooper Parry Group Limited
St James Building
79 Oxford Street
Manchester
M1 6HT
Bankers
Bank of America Merrill Lynch
2 King Edward Street
London
EC1A 1HQ
ALTERA HEALTHCARE (IT) UK LTD
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 21
ALTERA HEALTHCARE (IT) UK LTD
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present the strategic report for the year ended 31 December 2024.

Business review

The company’s revenues were consistent in 2024 compared with prior year as a result of low turnover of clients within the company’s customer base and steady sales. Costs increased from 2023 as a result of general economic conditions, this has contributed to an overall operating profit of £381k.

Key performance indicators

The company's key performance indicators during the year were its new orders taken. The company turnover in 2024 is £16,701k (2023 - £17,272k). In 2024, Altera UK had an order book of £8.3M compared to £3.7M order book in 2023.

Principal Risks and uncertainties

The main risks that the company is exposed to are, liquidity risk, price risk & credit risk.

Liquidity risk

The company seeks to manage liquidity risk by ensuring sufficient liquidity is available to meet foreseeable needs.

Price risk

The company constantly reviews both prices and supply of appropriately qualified labour, its key productive resource and adopts recruitment and retention policies to ensure that it is competitive and can attract sufficient suitable resources.

 

Credit risk

The company's credit risk is primarily attributable to trade debtors. The company makes both trade enquires and credit checks on all companies and institutions when it extends credit facilities.

On behalf of the board

T Richardson
Director
12 September 2025
- 1 -
ALTERA HEALTHCARE (IT) UK LTD
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company continued to be that of providing clinical, financial, connectivity and information solutions and related professional services to hospitals, physician practices and post acute organisations.

Results and dividends

The results for the year are set out on page 7.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

J Bender
T Richardson
Future developments

The company is striving to grow the business focusing on improving our core offerings and delivering software for life. Altera develops and elevates technology to connect and inspire healthier communities.

Auditor

The auditor, Cooper Parry Group Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

- 2 -
ALTERA HEALTHCARE (IT) UK LTD
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
On behalf of the board
T Richardson
Director
12 September 2025
- 3 -
ALTERA HEALTHCARE (IT) UK LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ALTERA HEALTHCARE (IT) UK LTD
Opinion

We have audited the financial statements of Altera Healthcare (IT) UK Ltd (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- 4 -
ALTERA HEALTHCARE (IT) UK LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ALTERA HEALTHCARE (IT) UK LTD (CONTINUED)
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors
- 5 -

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was considered capable of detecting irregularities including fraud

Irregularities, including fraud, are instances of non compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Identifying and assessing potential risks related to irregularities

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, we considered the following:

 

As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override.

 

We also obtained an understanding of the legal and regulatory frameworks the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the UK Companies Act and tax legislation.

ALTERA HEALTHCARE (IT) UK LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ALTERA HEALTHCARE (IT) UK LTD (CONTINUED)

In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty.

 

Our procedures to respond to risks identified included the following:

 

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Ryan Wear BSc ACA
Senior Statutory Auditor
For and on behalf of Cooper Parry Group Limited
Date:
17September 2025
2025-09-17
Statutory Auditor
St James Building
79 Oxford Street
Manchester
M1 6HT
- 6 -
ALTERA HEALTHCARE (IT) UK LTD
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
2024
2023
as restated
Notes
£'000
£'000
Turnover
3
16,701
17,272
Cost of sales
(5,755)
(6,141)
Gross profit
10,946
11,131
Administrative expenses
(10,565)
(6,295)
Operating profit
4
381
4,836
Interest receivable and similar income
6
-
0
105
Interest payable and similar expenses
7
(586)
(586)
(Loss)/profit before taxation
(205)
4,355
Tax on (loss)/profit
8
-
0
-
0
(Loss)/profit for the financial year
(205)
4,355

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

- 7 -
ALTERA HEALTHCARE (IT) UK LTD
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
2024
2023
As restated
Notes
£'000
£'000
£'000
£'000
Fixed assets
Tangible assets
10
194
256
Current assets
Debtors falling due after more than one year
11
1,064
2,062
Debtors falling due within one year
11
10,323
9,723
Cash at bank and in hand
4,000
2,245
15,387
14,030
Creditors: amounts falling due within one year
12
(7,138)
(6,766)
Net current assets
8,249
7,264
Total assets less current liabilities
8,443
7,520
Creditors: amounts falling due after more than one year
13
(19,968)
(18,840)
Net liabilities
(11,525)
(11,320)
Capital and reserves
Called up share capital
15
-
0
-
0
Other reserves
16
4,287
4,287
Profit and loss reserves
16
(15,812)
(15,607)
Total equity
(11,525)
(11,320)
The financial statements were approved by the board of directors and authorised for issue on 12 September 2025 and are signed on its behalf by:
T Richardson
Director
Company registration number 07584643 (England and Wales)
- 8 -
ALTERA HEALTHCARE (IT) UK LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
Capital contribution
Profit and loss reserves
Total
£'000
£'000
£'000
As restated for the period ended 31 December 2023:
Balance at 1 January 2023
4,287
(19,962)
(15,675)
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
4,355
4,355
Balance at 31 December 2022 As restated
4,287
(15,607)
(11,320)
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
(205)
(205)
Balance at 31 December 2024
4,287
(15,812)
(11,525)
- 9 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
Company information

Altera Healthcare (IT) UK Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 31 Temple Street, Birmingham, B2 5DB. The principal activity of the company is to provide clinical, financial, connectivity and information solutions and related professional services that empower hospital, physician practices and post-acute organisations.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £'000.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Constellation Software Inc at 31 December 2024 and copies of its consolidated financial statements can be obtained from the company at 20 Adelaide Street East, Suite 1200, Toronto, Ontario, Canada.

1.2
Going concern

The financial statements have been prepared under the going concern basis which assumes that the company will continue in operational existence for the foreseeable future. At the balance sheet date its liabilities exceeded its assets by £11,525k (2023 - £11,320k). true

 

At the period end the cash position of the company was strong £4,000k (2023 - £2,245k) however due to liabilities to fellow group companies at the year end, the company liabilities exceed its assets and therefore the company remains dependent on the support of the group. The directors have obtained written confirmation of the groups intention to continue to support the company in this way and have satisfied themselves that the group is in a position to provide the anticipated further support where necessary.

 

Therefore, the directors have a reasonable expectation that the company will be a going concern for the foreseeable future being a period of at least 12 months from the date of approval of these financial statements.

1.3
Turnover
- 10 -

Turnover comprises revenue recognised by the company in respect of goods and services supplied during the period. Turnover is measured at the fair value of the consideration received or receivable net of discounts and VAT.

Turnover from licensing arrangements in some products is recognised when contractual obligations have been met. This can be at a point in time or over time, depending on the contractual terms.

ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 11 -

Turnover from maintenance and support services is recognised over the term of the support agreement. Turnover from the sale of equipment and software is recognised when the economic risks and rewards are transferred to the third party.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
3 years straight line
Customer relationship
3 years straight line
Acquired technology
3 years straight line
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
Over the life of the lease or 3-4 years stright line
Plant and equipment
3-7 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

- 12 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

 

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the length of the lease term.

- 13 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
1.15
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

Preparation of the financial statements requires management to make significant judgements and estimates. The items in the financial statements where these judgements and estimates have been made include:

Revenue Recognition

Revenue is measured at the fair value of the consideration received or receivable, net of discounts and VAT. Estimation is used by management to allocate the contract value to each of the performance obligations contained within the contract.

 

Revenue form the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Revenue is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

3
Turnover and other revenue

All the company's turnover is attributable to its principal activity and arose within the United Kingdom. In respect of long-term contracts and contracts for on-going services, turnover represents the value of work done in the year, including estimates of amounts not invoiced. Turnover in respect of long-term contracts and contract for on-going services is recognised by reference to the stage of completion.

2024
2023
£'000
As restated
£'000
Turnover analysed by class of business
Services
15,750
15,228
Products
951
2,044
16,701
17,272
2024
2023
£'000
£'000
Other revenue
Interest income
-
105
- 14 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
4
Operating profit
2024
2023
Operating profit for the year is stated after charging/(crediting):
£'000
£'000
Exchange losses/(gains)
52
(153)
Fees payable to the company's auditor for the audit of the company's financial statements
35
40
Depreciation of tangible fixed assets
62
26
(Profit)/loss on disposal of tangible fixed assets
-
1
Operating lease charges
169
116
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Selling
12
8
Administration
9
10
Services
44
43
Total
65
61

Their aggregate remuneration comprised:

2024
2023
£'000
£'000
Wages and salaries
5,387
5,099
Social security costs
647
715
Pension costs
548
524
6,582
6,338
6
Interest receivable and similar income
2024
2023
£'000
£'000
Interest income
Interest on bank deposits
-
0
105
7
Interest payable and similar expenses
2024
2023
£'000
£'000
Interest on loans
586
586
- 15 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
8
Taxation

The actual charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£'000
as restated
£'000
(Loss)/profit before taxation
(205)
4,355
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
(51)
1,024
Tax effect of expenses that are not deductible in determining taxable profit
13
14
Tax effect of utilisation of tax losses not previously recognised
-
0
(748)
Unutilised tax losses carried forward
38
-
0
Adjustments in respect of prior years
-
0
(290)
Taxation charge for the year
-
-
9
Intangible fixed assets
Goodwill
Software
Customer relationship
Acquired technology
Total
£'000
£'000
£'000
£'000
£'000
Cost
At 1 January 2024
2,781
122
3,008
2,475
8,386
Disposals
(2,781)
(122)
(3,008)
(2,475)
(8,386)
At 31 December 2024
-
0
-
0
-
0
-
0
-
0
Amortisation and impairment
At 1 January 2024
2,781
122
3,008
2,475
8,386
Disposals
(2,781)
(122)
(3,008)
(2,475)
(8,386)
At 31 December 2024
-
0
-
0
-
0
-
0
-
0
Carrying amount
At 31 December 2024
-
0
-
0
-
0
-
0
-
0
At 31 December 2023
-
0
-
0
-
0
-
0
-
0
- 16 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
10
Tangible fixed assets
Leasehold improvements
Plant and equipment
Total
£'000
£'000
£'000
Cost
At 1 January 2024 and 31 December 2024
181
269
450
Depreciation and impairment
At 1 January 2024
11
183
194
Depreciation charged in the year
36
26
62
At 31 December 2024
47
209
256
Carrying amount
At 31 December 2024
134
60
194
At 31 December 2023
170
86
256
11
Debtors
2024
2023
£'000
as restated
Amounts falling due within one year:
£'000
Trade debtors
1,550
1,192
Amounts recoverable on contracts
711
1,374
Amounts owed by group undertakings
7,151
5,289
Other debtors
400
697
Prepayments and accrued income
511
1,171
10,323
9,723

A credit note provision of £252,468 (2023 - £22,237) was recognised against trade debtors during the year.

2024
2023
£'000
as restated
Amounts falling due after more than one year:
£'000
Amounts recoverable on contracts
1,064
2,062
Total debtors
11,387
11,785
- 17 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
12
Creditors: amounts falling due within one year
2024
2023
£'000
as restated
£'000
Trade creditors
1,147
2,082
Amounts owed to group undertakings
251
146
Accruals and deferred income
5,740
4,538
7,138
6,766
13
Creditors: amounts falling due after more than one year
2024
2023
£'000
£'000
Gross amounts owed to contract customers
6,073
5,532
Amounts owed to group undertakings
13,895
13,308
19,968
18,840

Amounts owed to group undertakings are unsecured. The interest rate per annum is equal to the Blended Annual Rate promulgated by the U.S. Internal Revenue Service, or 1.09%. Interest incurred during the year ended 31 December 2024 was £586k (2023 - £586k).

 

Amounts owed to group undertakings are due for repayment in full in September 2028.

14
Retirement benefit schemes
2024
2023
Defined contribution schemes
£'000
£'000
Charge to profit or loss in respect of defined contribution schemes
548
524

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

15
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Allotted, called up and fully paid
Ordinary shares of £1 each
100
100
100
100
16
Reserves
Capital contribution

Represents a statutory, non-distributable reserve into which amounts are transferred following the redemption or intercompany loans.

- 18 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
16
Reserves
(Continued)
Profit and loss reserves

Includes all current and prior period retained profits and losses.

17
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£'000
£'000
Within 1 year
174
130
Years 2-5
174
174
After 5 years
304
498
652
802
18
Related party transactions
Transactions with related parties

The company being a wholly owned subsidiary undertaking, has taken advantage of the exemption available under FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 33 Related party disclosures from disclosing transactions or balances with group companies on the grounds the consolidated accounts are publicly available.

 

The aggregate cost of key management personnel for 2024 was £474k (2023 - £1,331k).

19
Ultimate controlling party

The immediate parent undertaking is Altera Healthcare International Holdings, LLC incorporated in USA.

 

The ultimate parent company is Constellation Software Inc. a company domiciled in Canada. The address of Constellation Software Inc.'s registered office is 66 Wellington Street West, Suite 5300, Toronto, Ontario, Canada.

 

20
Prior period adjustment
Changes to the balance sheet
As previously reported
Adjustment at 1 Jan 2023
Adjustment at 31 Dec 2023
As restated at 31 Dec 2023
£'000
£'000
£'000
£'000
Current assets
Debtors due after one year
1,409
-
653
2,062
Debtors due within one year
9,287
(363)
799
9,723
Creditors due within one year
Other creditors
(12,445)
3,421
2,258
(6,766)
Creditors due after one year
Other creditors
(13,308)
-
(5,532)
(18,840)
Net assets
(12,556)
3,058
(1,822)
(11,320)
- 19 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
20
Prior period adjustment
(Continued)
As previously reported
Adjustment at 1 Jan 2023
Adjustment at 31 Dec 2023
As restated at 31 Dec 2023
£'000
£'000
£'000
£'000
Capital and reserves
Profit and loss reserves
(16,843)
3,058
(1,822)
(15,607)
Changes to the profit and loss account
As previously reported
Adjustment
As restated
Period ended 31 December 2023
£'000
£'000
£'000
Turnover
16,036
1,236
17,272
Profit for the financial period
4,355
3,119
1,236
Reconciliation of changes in equity
1 January
31 December
2023
2023
£'000
£'000
Adjustments to prior year
Contract liability
3,421
973
Contract Asset
(363)
263
Total adjustments
3,058
1,236
Equity as previously reported
(18,733)
(12,556)
Equity as adjusted
(15,675)
(11,320)
Analysis of the effect upon equity
Profit and loss reserves
3,058
1,236
Reconciliation of changes in profit for the previous financial period
2023
£'000
Adjustments to prior year
Contract liability
(141)
Contract Asset
1,377
Total adjustments
1,236
Profit as previously reported
3,119
Profit as adjusted
4,355
- 20 -
ALTERA HEALTHCARE (IT) UK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
20
Prior period adjustment
(Continued)
Notes to reconciliation
Contract Asset

Contract asset included accrued income have been increased by a prior year adjustment to the 2023 balances. The asset were increased by £1,377k.

Contract Liability

Contract liability included deferred income have been increased by a prior year adjustment to the 2023 balances. The liability was increased by £141k.

 

Directors response to restatement

During the year under review, the directors have assessed the treatment of the certain transaction affecting contract assets and liabilities, in light of this adjustment, a thorough review of the accounting processes of the company has been performed which did not result in any further errors.

- 21 -
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200J BenderT Richardson075846432024-01-012024-12-3107584643bus:Director12024-01-012024-12-3107584643bus:Director22024-01-012024-12-3107584643bus:RegisteredOffice2024-01-012024-12-3107584643bus:Agent12024-01-012024-12-31075846432024-12-31075846432023-01-012023-12-3107584643core:ContinuingOperations2023-01-012023-12-3107584643core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3107584643core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31075846432023-12-3107584643core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3107584643core:PlantMachinery2024-12-3107584643core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3107584643core:PlantMachinery2023-12-3107584643core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3107584643core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3107584643core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107584643core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3107584643core:Non-currentFinancialInstruments2024-12-3107584643core:Non-currentFinancialInstruments2023-12-3107584643core:ShareCapital2024-12-3107584643core:ShareCapital2023-12-3107584643core:OtherMiscellaneousReserve2024-12-3107584643core:OtherMiscellaneousReserve2023-12-3107584643core:RetainedEarningsAccumulatedLosses2024-12-3107584643core:RetainedEarningsAccumulatedLosses2023-12-3107584643core:RetainedEarningsAccumulatedLosses2022-12-3107584643core:Goodwill2024-01-012024-12-3107584643core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107584643core:ComputerSoftware2024-01-012024-12-3107584643core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107584643core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107584643core:LandBuildingscore:LongLeaseholdAssets2024-01-012024-12-3107584643core:PlantMachinery2024-01-012024-12-3107584643core:UKTax2024-01-012024-12-3107584643core:UKTax2023-01-012023-12-3107584643core:Goodwill2023-12-3107584643core:ComputerSoftware2023-12-3107584643core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-12-3107584643core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwill2023-12-31075846432023-12-3107584643core:Goodwill2024-12-3107584643core:ComputerSoftware2024-12-3107584643core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-12-3107584643core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwill2024-12-3107584643core:Goodwill2023-12-3107584643core:ComputerSoftware2023-12-3107584643core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-12-3107584643core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwill2023-12-3107584643core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3107584643core:PlantMachinery2023-12-3107584643core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-01-012024-12-3107584643core:CurrentFinancialInstruments2024-12-3107584643core:CurrentFinancialInstruments2023-12-3107584643core:Non-currentFinancialInstruments12024-12-3107584643core:Non-currentFinancialInstruments12023-12-3107584643core:WithinOneYear2024-12-3107584643core:BetweenTwoFiveYears2024-12-3107584643core:MoreThanFiveYears2024-12-3107584643bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107584643bus:FRS1022024-01-012024-12-3107584643bus:Audited2024-01-012024-12-3107584643bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP